VCG
AVNS icon

Vantage Consulting Group’s Avanos Medical AVNS Stock Holding History

Vantage Consulting Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-54
Closed -$2K – 233
2020
Q4 		$2K Buy
+54
New +$2.25K ﹤0.01% 1623

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vantage Consulting Group's AVNS Position: Q1 2021 in Review

Vantage Consulting Group sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 54 shares — an estimated $2K sold.

Vantage Consulting Group first reported a position in AVNS in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

  • Vantage Consulting Group reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 54 Avanos Medical shares in Q1 2021, an estimated $2K.
  • Vantage Consulting Group first reported a position in Avanos Medical in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Avanos Medical position peaked at $2K in Q4 2020.
  • 291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.